Literature DB >> 17068035

Monitoring renal function in hypertension.

Una Martin1, Jamie J Coleman.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17068035      PMCID: PMC1626286          DOI: 10.1136/bmj.38987.502512.DE

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


× No keyword cloud information.
  12 in total

Review 1.  Renal-artery stenosis.

Authors:  R D Safian; S C Textor
Journal:  N Engl J Med       Date:  2001-02-08       Impact factor: 91.245

2.  The natural history of incidental renal artery stenosis in patients with aortoiliac vascular disease.

Authors:  J I Iglesias; R J Hamburger; L Feldman; J S Kaufman
Journal:  Am J Med       Date:  2000-12-01       Impact factor: 4.965

3.  Practical recommendations for the use of ACE inhibitors, beta-blockers and spironolactone in heart failure: putting guidelines into practice.

Authors:  J McMurray; A Cohen-Solal; R Dietz; E Eichhorn; L Erhardt; R Hobbs; A Maggioni; I Pina; J Soler-Soler; K Swedberg
Journal:  Eur J Heart Fail       Date:  2001-08       Impact factor: 15.534

Review 4.  Renal dysfunction complicating the treatment of hypertension.

Authors:  Biff F Palmer
Journal:  N Engl J Med       Date:  2002-10-17       Impact factor: 91.245

Review 5.  When should atheromatous renal artery stenosis be considered? A guide for the general physician.

Authors:  John Main
Journal:  Clin Med (Lond)       Date:  2003 Nov-Dec       Impact factor: 2.659

6.  Treatment of heart failure with spironolactone--trial and tribulations.

Authors:  John J V McMurray; Eileen O'Meara
Journal:  N Engl J Med       Date:  2004-08-05       Impact factor: 91.245

Review 7.  Best practice in primary care pathology: review 6.

Authors:  W S A Smellie; J Forth; J J Coleman; W Irvine; P C Dore; G Handley; D G Williams; P J Galloway; K G Kerr; R Herriot; G P Spickett; T M Reynolds
Journal:  J Clin Pathol       Date:  2006-07-05       Impact factor: 3.411

8.  Angiotensin-converting enzyme inhibitor-associated elevations in serum creatinine: is this a cause for concern?

Authors:  G L Bakris; M R Weir
Journal:  Arch Intern Med       Date:  2000-03-13

9.  The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators.

Authors:  B Pitt; F Zannad; W J Remme; R Cody; A Castaigne; A Perez; J Palensky; J Wittes
Journal:  N Engl J Med       Date:  1999-09-02       Impact factor: 91.245

10.  Guidelines for management of hypertension: report of the fourth working party of the British Hypertension Society, 2004-BHS IV.

Authors:  B Williams; N R Poulter; M J Brown; M Davis; G T McInnes; J F Potter; P S Sever; S McG Thom
Journal:  J Hum Hypertens       Date:  2004-03       Impact factor: 3.012

View more
  1 in total

1.  Oversight: a retrospective study of biochemical monitoring in patients beginning antihypertensive drug treatment in primary care.

Authors:  Jamie J Coleman; Sarah E McDowell; Stephen J W Evans; Paramjit S Gill; Robin E Ferner
Journal:  Br J Clin Pharmacol       Date:  2010-07       Impact factor: 4.335

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.